Back to search

Article

Next-Generation Bruton’s tyrosine kinase Inhibitors plus Rituximab for Chronic Lymphocytic Leukemia-associated Membranoproliferative Glomerulonephritis: A Case Report

2025-12-02

Abstract excerpt

<title>Abstract</title> <p>Renal involvement in chronic lymphocytic leukemia (CLL) is rare but clinically significant. Among the various pathological types, membranoproliferative glomerulonephritis (MPGN) is the most common and often presents as nephrotic syndrome. Early recognition of the association between renal lesions and CLL is crucial for guiding treatment and improving both renal and hematologic outcomes....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73341aae-2b4c-5e50-939d-4f2f2e7dd746
DOI
10.21203/rs.3.rs-8195069/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Next-Generation Bruton’s tyrosine kinase Inhibitors plus Rituximab for Chronic Lymphocytic Leukemia-associated Membranoproliferative Glomerulonephritis: A Case ReportDOI 10.21203/rs.3.rs-8195069/v1
Select a neighboring publication to make it the new centre.